Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
How Nobel-winning optogenetics is being harnessed by biotechs
Fierce spoke to Nobel Prize winner Karl Deisseroth, M.D., Ph.D., and other optogenetics pioneers to discover how this science could benefit patients.
Darren Incorvaia
Oct 9, 2026 9:30am
‘It’s just survival’: Why a third of Boston lab space sits empty
Oct 8, 2026 8:00am
Mimetic’s peptide shows promise in reducing neuropathic pain
Oct 6, 2026 11:00am
How NIH’s Kleinstreuer reduces animal tests without ‘backlash’
Oct 6, 2026 8:00am
Trio of scientists win Nobel Prize for neuron light switch work
Oct 5, 2026 7:15am
Genentech's CEO on the next 50 years of the original biotech
Oct 1, 2026 8:00am
